| Execution period | Exercise period of 5 years from vesting |
|---|
NSE filing, NSE: ZENSARTECH. Summary written from the filing by ALFA Finder's alert engine.
Zensar Technologies Ltd: key numbers
- Share price
- ₹497.00
- Market cap
- ₹11,311 Cr
- Revenue (annual)
- ₹5,687 Cr
- Net profit (annual)
- ₹774.6 Cr
- P/E (TTM)
- 14.6×Sector 22.9×
- Promoter holding
- 48.98%-0.01% QoQ
- FII holding
- 10.21%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Zensar Technologies Ltd
All →Zensar Technologies Results Update
Zensar Technologies reported 4.1% sequential constant currency revenue growth to $166.2M for Q2FY27, with EBITDA margin at 15.8%. The release is a press release accompanying the quarterly results presentation.
Zensar Technologies Acquisition
Zensar's board approved merging its wholly owned subsidiary M3bi India into the parent. No consideration or share issuance is involved, and NCLT sanction is pending.
Zensar Technologies Q2 FY27 Results: Net Profit ₹190.2 Cr, Up 4.4% YoY
Zensar Technologies Ltd reported revenue from operations of ₹1,585 Cr (+11.5% YoY) and net profit of ₹190.2 Cr (+4.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹190.2 Cr · +4.4% YoY
Zensar Technologies Other Announcement
Zensar Technologies has been assigned an overall ESG rating of 76 in the 'Leader' category by NSE Sustainability Ratings and Analytics Limited.
Zensar Technologies Other Announcement
Zensar Technologies submitted its Regulation 74(5) compliance certificate for the quarter ended September 30, 2026, confirming RTA dematerialization records were furnished to depositories.
Zensar Technologies Employee Stock Options
Zensar Technologies allotted 162,619 equity shares upon the exercise of ESOPs by employees. This allotment increases the company's issued and subscribed share capital.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date